Lincoln National Corp’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-20,660
Closed -$245K 653
2024
Q1
$245K Buy
+20,660
New +$245K ﹤0.01% 1049